ZEAB Therapeutic engages Cresset Discovery Services to progress treatment for colorectal cancer
Cambridge, UK – 21 July 2020 – Cresset Discovery Services, a CRO for early phase discovery, has used computational tools ...
Syrris has partnered with Cresset to launch MedStere to increase lead optimisation efficiency.
Medstere is innovative bioisostere replacement software designed specifically for medicinal chemists. It shortens lead optimization cycles by suggesting thousands of obvious and non-obvious alternatives to a known lead. By intelligently ranking compounds from the view point of proteins it offers structurally diverse suggestions.
See the full press release here.